CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Grant or award Director acquired 7,043 shares (grant or award)
- 4 Open-market sale Exec VP Finance, CFO sold 123,100 shares at $11.25 ($1,385,220)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,126 shares (to pay taxes)
- 4 Shares withheld for taxes Exec VP Finance, CFO gave up 2,126 shares (to pay taxes)
- 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 1,772 shares (to pay taxes)
- 4 Grant or award Director acquired 7,137 shares (grant or award)
- 4 Grant or award Director acquired 7,137 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Exec. V.P. Finance, CFO gave up 5,930 shares (to pay taxes)
- 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 2,826 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 4,463 shares (to pay taxes)
- 4 Shares withheld for taxes President of R&D gave up 7,035 shares (to pay taxes)
- 4 Conversion Director acquired 116,535 shares (conversion)
- 4 Open-market sale Exec. VP Finance, CFO sold 150,000 shares at $9.27 ($1,390,635)
Page 8 of 28 · 560 filings